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Abstract
Hemoglobin (Hb) Grey Lynn is a Hb variant caused by a substitution of Phe for Leu at position 91 of α1-globin chain, originally described in individual 
of unknown ethnic background. This article addresses the interaction of Hb Grey Lynn with a non-deletional α+-thalassemia found in Thailand, a hi-
therto un-described condition. The proband was adult Thai woman referred for investigation of mild anemia with Hb 90 g/L. Hb analyses using low 
pressure liquid chromatography raised a suspicion of abnormal Hb presence, which was failed to demonstrate by cellulose acetate electrophoresis 
and capillary electrophoresis. DNA sequencing identified a CTT (Leu) to TTT (Phe) mutation at codon 91 corresponding to the Hb Grey Lynn (Vientia-
ne) [α91(FG3)Leu>Phe (α1) on α1-globin gene and a C deletion between codons 36 and 37 on α2-globin gene causing α+-thalassemia. As compared 
to those observed in a compound heterozygote for Hb Grey Lynn / α0-thalassemia reported previously, higher MCV (81.7 fL) and MCH (26.3 pg) va-
lues with a lower level of Hb Grey Lynn (19.7%) were observed in the proband. The normochromic normocytic anemia observed could be due to the 
interaction of Hb Grey Lynn with α+-thalassemia. The two mutations could be identified using PCR-RFLP and allele-specific PCR assays developed.
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The human globin genes are organized into two 
separated clusters, alpha (α) located on chromo-
some 16 and beta (β), on chromosome 11. The 
structure of α- cluster is 5’-ζ-ψζ-ψα2-ψα1-α2-α1-
θ-3’, with a regulatory element located upstream 
of the embryonic ζ-gene. For the β-cluster the or-
der is 5’-ε-Gγ-Aγ-ψβ-δ-β-3’ with the locus control 
region located upstream of the ε-globin gene (1). 
A normal adult individual has approximately 97.5% 
hemoglobin (Hb) A, 2.0 % Hb A2 and 0.5 % Hb F 
(2).
Inherited Hb disorders with absent or reduced syn-
thesis of particular globin chains are called tha-
lassemias, while Hb variants or abnormal Hbs are 
structurally inherited changes of globin chains. 
Both Hb variants and thalassemias have been in-
creasingly reported worldwide. To date, the HbVar 
database has noted more than 1,150 mutations (3). 
Although most of the Hb variants are non patho-
logical variants, some could produce clinically rel-
evant phenotypes when found in association with 
thalassemia or other hemoglobinopathies. Accu-
rate diagnoses of these hemoglobinopathies are 
important for planning of appropriate manage-
ment and genetic counseling. However, these are 
problematic in routine practice and usually require 
hematological, biochemical and molecular charac-
terizations (4-6). Many α-thalassemias are caused 
by deletions of one (α+-thalassemia) or both 
α-globin genes in cis (α0-thalassemia). Although 
point mutations or small deletions and insertions 
have been reported for non-deletional α-thalass-
emia, their frequencies are relatively much lower 
(7). While interaction of α+-thalassemia with α0-
thalassemia can cause Hb H disease, a thalassemia 
intermedia found commonly in the Southeast 
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Asian populations and Chinese, homozygous α0-
thalassemia leads to a fatal condition known as the 
Hb Bart’s hydrops fetalis. Most of the β-thalassemias 
are characterized by decreased or absent β-globin 
chain synthesis due to a variety of mutations. The 
majorities of the patients with homozygous β-tha-
lassemia develop a severe form of anemia and are 
transfusion dependent from the first year of life (8).
Hb Grey Lynn is an α-globin variant due to a Leu to 
Phe substitution at a position 91 of α1-globin chain. 
It was once reported in individual of unknown eth-
nic origin from New Zealand (9) and once again as 
Hb Vientiane found in association with Hb E in a 
Laotian (3). We have now reported for the first time 
the interaction of Hb Grey Lynn (Vientiane) 
[α91(FG3)Leu>Phe (α1)] with a rare α+-thalassemia 




Ethical approval was obtained from the Institu-
tional Review Board (IRB) of Khon Kaen University, 
Khon Kaen, Thailand (HE552035). The proband was 
adult Thai woman aged 28 years. She was discov-
ered at the ongoing thalassemia screening pro-
gram at provincial hospital. Because she had mod-
erate anemia with Hb 90 g/L (10) with the presence 
of unknown Hb variant, her EDTA anticoagulated 
blood specimen was transferred to our center for 
further investigation.
Laboratory methods
Erythrocyte number, Hb level and erythrocyte in-
dices were measured and calculated on blood cell 
counter (COULTER®HmX Hematology Analyzer; 
Beckman Coulter Co.-, Miami, FL, USA). Plasma fer-
ritin concentration was assayed using chemilumi-
nescent immunoassay on the Syncron LXi 725 Ac-
cess® Clinical System (Beckman Coulter, USA). Hb 
analysis was done using cellulose acetate electro-
phoresis (CAE) (11), automated low performance 
liquid chromatography (LPLC) (Hb Gold; Drew Sci-
entific Co., Ltd., Cumbria, UK), and capillary elec-
trophoresis (Capillarys 2 Flex Piecing; Sebia, Lisses, 
France) (Figure 1), applying protocols provided by 
the manufacturers.
Genomic DNA was prepared from peripheral 
blood leukocyte as previously described (12). Test-
ing for the presence of α0-thalassemia (--SEA and 
--THAI), α+-thalassemia (-α3.7 and -α4.2), Hb Constant 
Spring (αCSα or HBA2:c.427T>C) and Hb Pakse′ 
(αPSα or HBA2:c.429A>T) commonly found in Thai-
land, was performed using polymerase chain reac-
tion (PCR) based methods as described elsewhere 
(13,14). Previously described multiplex allele spe-
cific PCR assays were used to check the presence 
of mutations detected in patients previously re-
ferred to our laboratory: Hb Hekinan [α27(B8)Glu 
→ Asp or HBA2:c.84G>C], Hb Nakhon Ratchasima 
[α63(E12)Ala → Val or HBA2:c.191C>T] and Hb 
Phnom Penh [α117(GH5)-Ile-α118(H1) or HBA1:p.
Phe118_Thr119insIle] (15,16). DNA sequencing of 
amplified α1- and α2-globin genes were per-
formed using specific primers and an ABI PRISMTM 
3130 XL analyzer (Applied Biosystems, Foster City, 
CA, USA) (17).
Identification of Hb Grey Lynn mutation
The PCR-RFLP assay was developed for identifica-
tion of Hb Grey Lynn mutation on α1-globin gene. 
Selective amplification of α1-globin specific frag-
ment (975 bp) was performed by PCR using prim-
ers C1 (5′-TGG AGG GTG GAG ACG TCC TG-3’) and B 
(5’-GAG GCC CAA GGG GCA AGA AGC AT-3’) (16). 
The PCR product was digested to completion with 
HindIII restriction enzyme (5’-A▼AGCTT-3’) (New 
England Biolabs, Beverly, MA, USA) (NEBcutter 
V2.0, http://tools.neb.com/NEBcutter2/). After di-
gestion, normal control fragment is digested into 
627 bp and 348 bp fragments whereas the 975 bp 
fragment is specific for Hb Grey Lynn.
Identification of α+-thalassemia [α2 codon 
36/37 (-C)]
An allele-specific PCR assay was developed for 
identification of the α2 codon 36/37 (-C) α+-
thalassemia mutation. In this assay, primer αG58 
(5’-AGG ATG TTC CTG TCC TTC CCA-3’), specific to 
this mutation is used with a common primer C3 
(5’-CCA TTG TTG GCA CAT TCC GG-3’) to produce 
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the 634 bp mutation specific fragment. The 391 bp 
fragment produced with primers αG17 (5’-AGA 
TGG CGC CTT CCT CTC AGG-3’) and C3 is used as 
an internal control of PCR amplification. The PCR 
reaction mixture (50 µl) contains 50-100 ng of ge-
nomic DNA, 30 pmol of primers αG58 and C3, 3 
pmol of primer αG17, 200 µM dNTPs, 0.75 M 
betaine, 5% DMSO and 1.5 unit Taq DNA polymer-
ase (New England Biolab, Inc., USA) in 12 mM Tris-
HCl buffer pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.01% 
gelatin. PCR amplification was carried out on a T-
Personal Thermocycler (Biometra; GmbH, Gottin-
gen, Germany). After initial heat activation step of 
3 minutes at 94°C, 30 cycles were repeated under 
the following conditions: 30 sec at 94 °C, 30 sec at 
62 °C and 2 min at 68 °C. The amplified product 
was separated on 1.5 % agarose gel electrophore-
sis and visualized under UV light after ethidium 
bromide staining.
Results
Hematologic analysis of the proband revealed Hb 
90 g/L and MCH 26.3 pg (Table 1). Plasma ferritin 
concentration (75 µg/L) was within reference range 
(20-300 µg/L) (18) which ruled out iron deficiency 
anemia. Other hemolysis markers including reticu-
locyte count, serum bilirubin, haptoglobin and he-
mopexin levels were not examined at that time. 
Although initial Hb analysis on cellulose acetate 
electrophoresis identified no abnormal Hb (Figure 
1A), analysis using LPLC analyzer identified 63.6 % 
Hb A, 3.1 % Hb A2 and 19.7 % unknown Hb sepa-
rating between Hb A and Hb A2 at the Hb E-win-
dow, quite resembling Hb E heterozygote (Figure 
1B). Inconsistency with this finding included a neg-
ative result for the dichlorophenolindophenol 
(DCIP) screening test for Hb E and the result of Hb 
analysis using capillary electrophoresis, which 
showed 85.4 % Hb A and 2.6 % Hb A2, with no Hb 
E nor abnormal Hb peak noted (Figure 1C). Routine 
molecular screening for α-thalassemia mutations 
commonly found in Thailand revealed negative re-
sults. Screening for Hb Hekinan, Hb Nakhon Ratch-
asima and Hb Phnom Penh mutations revealed 
negative results. Further DNA sequencing of α1 
and α2-globin genes of the patient identified the 
CTT (Leu) to TTT (Phe) substitution at codon 91 on 
α1-globin gene corresponding to the Hb Grey Lynn 
(9) or Hb Vientiane (3) (Figure 2A) (Hb Grey Lynn 
and Hb Vientiane are synonyms) and identified a 
(-C) deletion between codons 36 and 37 of α2-
globin gene [α2 codon 36/37 (-C)] (or 
HBA2:c.112delC) leading to a premature termina-
tion at a new codon 48 as shown in Figure 2B. The 
patient was therefore confirmed to be a com-
pound heterozygote for Hb Grey Lynn and α+-
thalassemia [α2 codon 36/37 (-C)], a hitherto un-
described condition.
As the Hb Grey Lynn mutation eliminates a HindIII 
restriction site at codon 91 of α1-globin gene, PCR-
RFLP method, as shown in Figure 3A, was con-
firmed as applicable for detection of this variant. 
Regarding targeted detection C deletion between 
codons 36/37 of α2-globin gene (or HBA2:c.112delC), 
reliable results were achieved by using allele spe-
Figure 1. Hb analysis using cellulose acetate electrophoresis (A). 1-3 are the proband, normal control and Hb E carrier, respectively. B 
and C are Hb analysis profiles of the proband using automated LPLC and capillary electrophoresis, respectively.
A B C
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Figure 2. DNA sequence profiles of the proband demonstrating a CTT (Leu) to TTT (Phe) mutation at codon 91 of α1-globin gene cor-
responding to the Hb Grey Lynn (A) and a C deletion between codons 36 and 37 of α2-globin gene leading to a premature termina-







Proband Hb Grey Lynn
/ α+-thalassemia
(This study)







(M - male, 
F - female)
Gender / Age (year) Female / 28 Female / 40 NA / NA Male / 61 -
Origin Thai NA Laotian Italian -
RBC (x 1012/L) 3.4 5.2 4.3 4.8 M: 4.5-5.9, F: 4.5-5.1
Hb (g/L) 90.0 103 114 139 M: 135-175, F: 120-155
HCT (%) 28.0 33.0 34.9 41.6 M: 40.0-50.0, F: 36.0-45.0
MCV (fL) 81.7 63.0 80.8 86.6 80.0-95.0
MCH (pg) 26.3 19.7 26.4 28.8 27.0-34.0
MCHC (g/L) 321 312 327 334 320-360
Hb A2 & E (%) 3.1 * 3.0 NA 2.2 -
Hb F (%) < 0.5 * 2.0 NA 0.2 -
Hb Grey Lynn (%) 19.7 * 35.5 15.0 15.3 -
α-genotype ααHb Grey Lynn/α36/37α ααHb Grey Lynn/--SEA ααHb Vientiane/αα αHb Trevisoα/αα -
β-genotype βA/βA βA/βA βE/βA βA/βA -
* Determined using Hb-LPLC analyzer. NA - not available; RBC - red blood cells; Hb - haemoglobin; HCT - haematocrit; MCV - 
mean corpuscular volume; MCH - mean corpuscular hemoglobin; MCHC - mean corpuscular hemoglobin concentration; (-α3.7): 
α+-thalassemia (3.7 kb deletion), (--SEA): α0-thalassemia (Southeast Asian deletion).
Table 1. Hematological parameters of the proband with Hb Grey Lynn and α+-thalassemia as compared to those of subjects with Hb 
Grey Lynn and α0-thalassemia, Hb Vientiane / Hb E and Hb Treviso trait, reported previously.
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cific PCR assay as shown in Figure 3B. Hematologi-
cal parameters of this Thai patient were compared 
with those of the previously documented cases of 
compound heterozygote for Hb Grey Lynn / α0-
thalassemia (9), double heterozygote for Hb Vien-
tiane / Hb E (3) and heterozygous Hb Treviso with 
the same mutation on α2-globin gene [α91(FG3)
Leu→Phe (α2)] recently reported (19) (Table 1). As 
compared to those observed in a compound het-
erozygote for Hb Grey Lynn / α0-thalassemia, rela-
tively normal MCV and MCH values were noted in 
a compound heterozygote for Hb Grey Lynn / α+-
thalassemia (the proband), double heterozygote 
for Hb Grey Lynn / Hb E and Hb Treviso trait.
Discussion
We report for the first time in this study interaction 
of Hb Grey Lynn (Vientiane) [α91(FG3)Leu>Phe (α1)] 
with a rare α+-thalassemia point mutation [α2 co-
don 36/37 (-C)]. Hb Grey Lynn has been document-
ed in individual of unknown ethnic background in 
Auckland, New Zealand in the presence of α0-
thalassemia (9). It has been noted again in 2007, as 
Hb Vientiane in association with Hb E in a Laotian 
subject (3). In both patients neither Hb H nor tha-
lassemia phenotype was observed. The variant ex-
hibited mild instability and altered O2 affinity since 
substitution of Phe for Leu at position 91 of α1-
globin chain could affect heme interactions and 
α1β2 contact (9). Similar findings have been noted 
for another Hb variant with the same mutation but 
described alternatively on the α2-globin gene i.e. 
Figure 3. A: Identification of the Hb Grey Lynn mutation by PCR-RFLP assay using HindIII digestion. The locations of primers C1 and B 
used to generate an α1 specific fragment of 975 bp by PCR are shown. Normal control fragment is digested into two fragments with 
627 bp and 348 bp in lengths while the undigested 975 bp fragment indicates the presence of Hb Grey Lynn mutation. M represents 
the GeneRuler 50 bp Plus DNA ladder. 1: amplified DNA of the proband, 2: HindIII-digested amplified DNA of a normal control, and 3: 
HindIII-digested amplified DNA of the proband with Hb Grey Lynn.
B: Identification of α+-thalassemia [α2 codon 36/37 (-C)] by allele specific PCR. The locations and orientations of primers (αG17 & C3) 
and (αG58 & C3) used respectively to produce the 634 bp α2 codon 36/37 (-C) mutation specific fragment and the 391 bp internal 
control fragment are depicted. M represents the GeneRuler 50 bp Plus DNA ladder. The α2 codon 36/37 (-C) mutation was identified 
in the proband (lane 2) but not in a normal control (lane 1).
A B
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the Hb Treviso [α91(FG3)Leu-Phe(α2)] found in an 
Italian subject (19).
As shown in Table 1, it seems likely that the mild 
instability and decreased O2 affinity of these Hb 
variants do not produce significant hematological 
phenotype of the patients. However, with the lack 
of additional laboratory results especially for meas-
urement of hemolysis markers e.g. reticulocyte 
count, serum bilirubin, lactate dehydrogenase, and 
haptoglobin, we could not exclude in vivo hemoly-
sis. This is a limitation of our case report although 
no evidence was observed in the cases reported 
previously (9,19). The moderate normochromic 
normocytic anemia observed in the Thai patient 
described here could be due to the interaction of 
Hb Grey Lynn with α+-thalassemia. Iron deficiency 
has been excluded. In fact, it has been shown pre-
viously that thalassemia and hemoglobinopathies 
rather than iron deficiency are major causes of 
anemia in the region (20,21).
Among approximately 400 α-globin chain variants 
documented, about 20 variants have been found 
on both α1- and α2-globin genes (3). Although 
these mutations lead to identical α-globin chain 
variants, they are considered as different muta-
tional events. The average proportion of Hb vari-
ant due to α2-globin gene mutation is usually 
higher than that of the same mutation on α1-
globin gene for the higher expression of α2-globin 
gene (22). This however could be changed with a 
genetic compound heterozygosis. As shown in Ta-
ble 1, in heterozygote form the level of Hb Grey 
Lynn is detected at around 15 % (Hb Treviso trait). 
However, elevated levels could be seen with co-
inheritance of α+-thalassemia (the proband; 19.7%) 
and α0-thalassemia (35.5%), likely because of the 
decreased availability of normal α-globin chain 
with these conditions.
Most of the α-thalassemias in Thai and other 
Southeast Asian populations are caused by gene 
deletions (23). The finding of a relatively rare and 
previously un-described in Thai population, the 
α+-thalassemia due to codon 36/37 (-C) mutation 
indicates that α-thalassemia due to point mutation 
may not be uncommon in the population. This 
frameshift mutation results in a premature termi-
nation of α-globin chain synthesis at codon 48 
which should trigger an increased mRNA degrada-
tion via a nonsense-mediated mRNA decay (NMD) 
mechanism (24). According to currently available 
literature, this α-thalassemia associated mutation 
has not been described before, though it was de-
posited as an α2 codon 37 (-C) at the HbVar data-
base (3). No ethnic background and clinical pheno-
type of the case is provided. Due to the lack of 
family analysis of our patient who was a com-
pound heterozygote for this unpublished α+-
thalassemia mutation on α2-globin gene and Hb 
Grey Lynn on α1-globin gene, we do not know for 
certain if both mutations are located in cis or in 
trans on the α-globin gene cluster. Identification of 
Hb Grey Lynn but not this α+-thalassemia mutation 
in two cases reportedly previously (Table 1) indi-
cates likely that these two mutations are located in 
trans. We do not know the exact prevalence of this 
non-deletional α+-thalassemia mutation in Thai 
population. Nonetheless, it is conceivable that in-
teraction of this α+-thalassemia mutation with α0-
thalassemia and/or Hb E could lead to a severe Hb 
H or AEBart’s disease commonly encountered in 
the region (25). Accurate diagnosis is essential for 
genetic counseling and treatment planning of the 
case.
It is noteworthy as shown in Figure 1 that diagno-
sis of Hb Grey Lynn at routine Hb analysis might be 
problematic as it co-migrates with Hb A on cellu-
lose acetate electrophoresis and is not completely 
separated from Hb A on chromatography. In addi-
tion, a substitution of Phe for Leu at position 91 of 
α1-globin chain does not modify the net charge of 
the Hb molecule, capillary electrophoresis cannot 
detect it either. This result highlights the impor-
tance of timely diagnosis of abnormal Hbs by mul-
tiple methods at hematological, Hb analysis and 
molecular levels. Combined analyses using cellu-
lose acetate electrophoresis, LPLC or HPLC and 
capillary electrophoresis would be a better alter-
native when possible. The result of these Hb analy-
ses should provide useful information for selection 
of appropriate molecular testing in the final diag-
nosis of such variants. The characterization meth-
ods described here should prove useful on this 
matter.
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